Pancreatic Cancer Research

Digest Map Explore About

Open data from ClinicalTrials.gov, Europe PMC, NIH RePORTER and OpenAlexFor research and education, not medical adviceAbout this project

The Pancreatic Cancer Research Digest

New trials, papers and changes to existing records, compiled daily from the public registries

Sunday, September 27, 202610 items · 0 changes to existing records

← Previous day Next day →

New paper

Reporting Odds Ratio Analysis of Gemcitabine-Based Chemotherapy Regimens for Biliary and Pancreatic Cancer: Population-Level Toxicity Signals and Hypotheses for High-Altitude Generalizability

Why it was picked newest record on or before this date

DOI 10.64898/2026.09.24.26363686 ↗ Sep 27, 2026

In this edition

New trials: 0
New papers: 10
New grants: 0
Other new records: 0
Status changes: 0
Results posted: 0
Retractions: 0
Other updates: 0

New paper

Pancreatic Cancer-Associated Pain Management Beyond Opioids: Integrating Oncological Treatment, Palliative Care, and Interventional Pain Medicine.

Why it was picked newest record on or before this date

DOI 10.3390/cancers18193127 ↗ Sep 27, 2026

New paper

Adjuvant Chemotherapy Is Not Associated With Improved Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma With Persistent Lymphovascular Invasion or Lymph Node Involvement After Neoadjuvant Chemotherapy.

Why it was picked newest record on or before this date

DOI 10.1002/jso.70414 ↗ Sep 27, 2026

New paper

Association of Alcohol Consumption with Risk of Pancreatic Cancer: A Systematic Review and Dose-Response Meta‑Analysis of Prospective Cohort Studies.

Why it was picked newest record on or before this date

DOI 10.1080/01635581.2026.2735062 ↗ Sep 27, 2026

New paper

Missed Opportunities for Multimodality Therapy in Resectable Pancreatic Cancer: National Disparities and Consequences for Survival.

Why it was picked newest record on or before this date

DOI 10.1002/jso.70408 ↗ Sep 27, 2026

Also today

New paper

Acute extensive portal vein system thrombosis in a patient with acute pancreatitis secondary to pancreatic cancer.

DOI 10.15403/jgld-6722 ↗ Sep 27, 2026

New paper

Beyond Surgery: Does Adjuvant Therapy Still Add Value for Patients With Pancreatic Cancer After Neoadjuvant Treatment?

DOI 10.1245/s10434-026-20630-3 ↗ Sep 27, 2026

New paper

Editorial Comment: What's in an Accreditation? Cancer Center Designation and Outcomes in Pancreatic Cancer.

DOI 10.1245/s10434-026-20625-0 ↗ Sep 27, 2026

New paper

Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Localized Pancreatic Cancer: Trans-Atlantic Pancreatic Surgery Consortium Study.

DOI 10.1245/s10434-026-20620-5

Editor’s note

Not in the data yet: changes to existing records. Status changes, newly posted results and retractions need a history of each record, which is not collected yet. Until then the digest lists new records only.

Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.

·

Sep 27, 2026

New paper

Neutral Inonotus obliquus polysaccharide (IOP-W): Structural characterization and p53/MAPK-mediated apoptotic activity against pancreatic Cancer unveiled through multi-omics.

DOI 10.1016/j.ijbiomac.2026.154618 ↗ Sep 27, 2026